Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis
Larger studies with longer-term follow-up are required to further confirm the effects of avapritinib on anaphylaxis in patients with SM.
Authors
- Cecilia Arana Yi
- Sonia Cerquozzi (ORCID: https://orcid.org/0000-0001-9027-1776)
- Vidushi Swarup (ORCID: https://orcid.org/0000-0002-4836-7245)
- Friederike Wortmann (ORCID: https://orcid.org/0000-0002-8684-1710)
- Pankit J. Vachhani (ORCID: https://orcid.org/0000-0001-9779-6217)
- Ingunn Dybedal (ORCID: https://orcid.org/0000-0002-3229-3069)
- Cristina Morales Cabeza
- Kate J. Newberry (ORCID: https://orcid.org/0000-0001-9294-5965)
- Cem Akin
- Karin Hartmann
- Jens Peter Panse
- Ilda Bidollari
- Peter Vadas
- Jason Gotlib
- Ivan Alvarez-Twose
- Mariana Castells
- Thanai Pongdee
- Daniel Shaheen
Institutions
- Oslo University Hospital (NO)
- Brigham and Women's Hospital (US)
- St. Michael's Hospital (CA)
- University of Calgary (CA)
- University of Basel (CH)
- University of Michigan (US)
- University Hospital of Basel (CH)
- University of Alabama at Birmingham (US)
- Spanish Multiple Sclerosis Network (ES)
- Integrated Oncology (United States) (US)
- Hospital Virgen del Valle (ES)
- Blueprint Medicines (United States) (US)
- Mayo Clinic in Arizona (US)
- Stanford Medicine (US)
- Praxis für Hämatologie und Onkologie (DE)
- Servicio de Salud de Castilla La Mancha (ES)
- Mayo Clinic in Florida (US)
- RWTH Aachen University (DE)
- Stanford University (US)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2026-03-14
- DOI
- https://doi.org/10.1016/j.waojou.2026.101352
- Primary Topic
- Mast cells and histamine
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi